These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 74583)

  • 1. Cytomegalovirus vaccination and renal transplantation.
    Glazer JP; Friedman HM; Grossman RA; Barker CF; Starr SE; Plotkin SA
    Lancet; 1978 Jan; 1(8055):90-1. PubMed ID: 74583
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of cytomegalovirus disease by Towne strain live attenuated vaccine.
    Plotkin SA; Smiley ML; Friedman HM; Starr SE; Fleisher GR; Wlodaver C; Dafoe DC; Friedman AD; Grossman RA; Barker CF
    Birth Defects Orig Artic Ser; 1984; 20(1):271-87. PubMed ID: 6329367
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial.
    Balfour HH; Sachs GW; Welo P; Gehrz RC; Simmons RL; Najarian JS
    Birth Defects Orig Artic Ser; 1984; 20(1):289-304. PubMed ID: 6329368
    [No Abstract]   [Full Text] [Related]  

  • 4. Should renal-transplant patients be screened for C.M.V.?
    Lancet; 1978 Oct; 2(8093):770-1. PubMed ID: 80691
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus vaccine in renal transplants.
    Betts RF
    Ann Intern Med; 1979 Nov; 91(5):780-2. PubMed ID: 227302
    [No Abstract]   [Full Text] [Related]  

  • 6. Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial.
    Glazer JP; Friedman HM; Grossman RA; Starr SE; Barker CF; Perloff LJ; Huang ES; Plotkin SA
    Ann Intern Med; 1979 Nov; 91(5):676-83. PubMed ID: 227299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against human cytomegalovirus with live virus.
    Plotkin SA; Friedman HM; Starr S; Fleisher G
    Dev Biol Stand; 1982; 52():373-9. PubMed ID: 6299846
    [No Abstract]   [Full Text] [Related]  

  • 8. Live cytomegalovirus vaccination of healthy volunteers: eight-year follow-up studies.
    Stern H
    Birth Defects Orig Artic Ser; 1984; 20(1):263-9. PubMed ID: 6329366
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of cytomegalovirus disease following renal transplantation.
    Hanshaw JB
    Am J Dis Child; 1977 Aug; 131(8):841-5. PubMed ID: 196502
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of cytomegalovirus in organ transplantation].
    Aguado JM
    Rev Clin Esp; 1996 Apr; 196(4):240-7. PubMed ID: 8701064
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Vaccination against cytomegalovirus?
    Pagano JS; Huang ES
    Lancet; 1974 Feb; 1(7852):316-7. PubMed ID: 4130502
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of morbidity and mortality of wild murine cytomegalovirus by vaccination with attenuated cytomegalovirus.
    Howard RJ; Balfour HH
    Proc Soc Exp Biol Med; 1977 Nov; 156(2):365-8. PubMed ID: 200952
    [No Abstract]   [Full Text] [Related]  

  • 13. Acyclovir to prevent cytomegalovirus infection after renal transplantation.
    Wong T; Toupance O; Chanard J
    Ann Intern Med; 1991 Jul; 115(1):68. PubMed ID: 1646586
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis of cytomegalovirus infection in renal transplantation.
    Kuypers DR; Vanrenterghem Y
    Nephrol Dial Transplant; 1998 Dec; 13(12):3012-6. PubMed ID: 9870456
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated immunity to cytomegalovirus in mice and in renal transplant recipients.
    Howard RJ; Balfour HH
    Transplant Proc; 1979 Mar; 11(1):75-8. PubMed ID: 222021
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship of epidemiology and treatment factors to infection and allograft survival in renal transplantation.
    Betts RF
    Birth Defects Orig Artic Ser; 1984; 20(1):87-99. PubMed ID: 6329375
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytomegalovirus infections in transplant patients: methods of prevention of primary cytomegalovirus.
    Bowden RA
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):136-8, discussion 138. PubMed ID: 1648818
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections.
    Cheeseman SH; Rubin RH; Stewart JA; Tolkoff-Rubin NE; Cosimi AB; Cantell K; Gilbert J; Winkle S; Herrin JT; Black PH; Russell PS; Hirsch MS
    N Engl J Med; 1979 Jun; 300(24):1345-9. PubMed ID: 220536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus disease in renal transplantation.
    Newstead CG
    Nephrol Dial Transplant; 1995; 10 Suppl 1():68-73. PubMed ID: 7617284
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of cytomegalovirus disease in transplant recipients.
    Pidgeon GB; Bailey RR
    N Z Med J; 1993 Nov; 106(967):468-9. PubMed ID: 8233192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.